Why the study?
Does deactivating CRT therapy reduce ventricular arrhythmias or improve survival in patients with LVAD support?
Population
158 patients with active CRT devices who underwent continuous-flow LVAD implantation, excluding those who…
Comparison
Deactivation of CRT therapy during LVAD support vs Continuation of CRT therapy (CRT-on)
Design
Cohort
Follow-up
3 years
Key result
CRT deactivation in LVAD patients had no significant impact on 1-year ventricular arrhythmia incidence (40% vs 37%, p=0.649) but was associated with improved 3-year transplant-free survival.
Authors
Loading...
CRT deactivation was associated with better transplant-free survival post-LVAD; observational data leave open need for randomized confirmation.
Cohort (n=158)
No
Does deactivating CRT therapy reduce ventricular arrhythmias or improve survival in patients with LVAD support?
Absolute Event Rate: 40% vs 37%
p-value: p=0.649
Deactivating CRT in LVAD patients does not increase ventricular arrhythmias and may be associated with improved transplant-free survival.
Efimova et al. (2026) conducted a cohort in LVAD patients with an active CRT device (n=158). CRT deactivation vs. CRT continuation (CRT-on) was evaluated on Incidence of ventricular arrhythmias within the first year (p=0.649). CRT deactivation in LVAD patients had no significant impact on 1-year ventricular arrhythmia incidence (40% vs 37%, p=0.649) but was associated with improved 3-year transplant-free survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: